The purpose of this study is to assess the safety of DMP 754. DMP 754 is a new drug which has the potential to be an oral anti-platelet medicine which may decrease the likelihood and severity of developing clots in arteries which can result in heart attacks or strokes.
Showing the most recent 10 out of 266 publications